605 related articles for article (PubMed ID: 25386819)
1. Targeting the NFκB signaling pathways for breast cancer prevention and therapy.
Wang W; Nag SA; Zhang R
Curr Med Chem; 2015; 22(2):264-89. PubMed ID: 25386819
[TBL] [Abstract][Full Text] [Related]
2. The NFkappaB pathway and endocrine-resistant breast cancer.
Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
[TBL] [Abstract][Full Text] [Related]
3. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
[TBL] [Abstract][Full Text] [Related]
4. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC
BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600
[TBL] [Abstract][Full Text] [Related]
5. Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.
Zhou Y; Eppenberger-Castori S; Marx C; Yau C; Scott GK; Eppenberger U; Benz CC
Int J Biochem Cell Biol; 2005 May; 37(5):1130-44. PubMed ID: 15743683
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges.
Guo Q; Jin Y; Lin M; Zeng C; Zhang J
Life Sci; 2024 Jul; 348():122684. PubMed ID: 38710275
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
[TBL] [Abstract][Full Text] [Related]
8. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
Wu JT; Kral JG
J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
[TBL] [Abstract][Full Text] [Related]
10. NFkappaB: a promising target for natural products in cancer chemoprevention.
Luqman S; Pezzuto JM
Phytother Res; 2010 Jul; 24(7):949-63. PubMed ID: 20577970
[TBL] [Abstract][Full Text] [Related]
11. NFkappaB-dependent chemoresistance in solid tumors.
Arlt A; Schäfer H
Int J Clin Pharmacol Ther; 2002 Aug; 40(8):336-47. PubMed ID: 12467302
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
13. NFκB inhibitors induce cell death in glioblastomas.
Zanotto-Filho A; Braganhol E; Schröder R; de Souza LH; Dalmolin RJ; Pasquali MA; Gelain DP; Battastini AM; Moreira JC
Biochem Pharmacol; 2011 Feb; 81(3):412-24. PubMed ID: 21040711
[TBL] [Abstract][Full Text] [Related]
14. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy.
Shen HM; Tergaonkar V
Apoptosis; 2009 Apr; 14(4):348-63. PubMed ID: 19212815
[TBL] [Abstract][Full Text] [Related]
15. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
16. Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA
Tu SH; Chiou YS; Kalyanam N; Ho CT; Chen LC; Pan MH
Food Funct; 2017 Mar; 8(3):1067-1079. PubMed ID: 28145547
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
[TBL] [Abstract][Full Text] [Related]
20. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]